AGRX - Agile Therapeutics Inc. (AGRX) CEO Alfred Altomari on Q3 2020 Results - Earnings Call Transcript
Agile Therapeutics, Inc. (AGRX) Q3 2020 Earnings Conference Call November 12, 2020 16:30 ET Company Participants Matthew Riley - Investor Relations Alfred Altomari - Chairman, President & Chief Executive Officer Dennis Reilly - Senior Vice President & Chief Financial Officer Conference Call Participants Randall Stanicky - RBC Capital Markets Oren Livnat - H.C. Wainwright Timothy Lugo - William Blair & Company Leland Gershell - Oppenheimer Paul Biedlingmaier - Edward Jones Presentation Operator Good afternoon and welcome to the Agile Therapeutics Third Quarter 2020 Financial Results Conference Call. Please note today's event is being recorded. At this time all participants are in a listen-only mode. A brief question and answer session will follow the formal presentation. [Operator Instructions] I would now like to turn the conference over to Matt Riley, Head of Investor Relations. Matthew Riley Hello, everyone and welcome to today's conference call to discuss our third quarter 2020 financial
For further details see:
Agile Therapeutics, Inc. (AGRX) CEO Alfred Altomari on Q3 2020 Results - Earnings Call Transcript